TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Galena Pharma Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover | 3,727 | 3,181 | |
Financial expenses | 1 | 10 | 11 |
Earnings before taxes | 355 | 21 | 219 |
Total assets | 2,060 | 1,603 | 1,390 |
Current assets | 183 | 203 | 878 |
Current liabilities | 1,044 | 1,134 | 644 |
Equity capital | 666 | 368 | 547 |
- share capital | 326 | 326 | 326 |
Employees (average) | 25 | 20 | 19 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency | 32.3% | 23.0% | 39.4% |
Turnover per employee | 186 | 167 | |
Profit as a percentage of turnover | 0.6% | 6.9% | |
Return on assets (ROA) | 17.3% | 1.9% | 16.5% |
Current ratio | 17.5% | 17.9% | 136.3% |
Return on equity (ROE) | 53.3% | 5.7% | 40.0% |
Change turnover | 546 | 414 | |
Change turnover % | 17% | 15% | |
Chg. No. of employees | 5 | 1 | 0 |
Chg. No. of employees % | 25% | 5% | 0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.